Please log in to view this page
Username
Password
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
